JAK Inhibitor Tofacitinib Ameliorates Inflammation Response and Osteogenic Differentiation in Immune‐Mediated Inflammatory Arthritis in Rats

International Journal of Rheumatic Diseases · Published 2026-07-01 · DOI 10.1111/1756-185x.70773

Free full text

Authors (10)

Zhiming Zhang, Zhiming Lin, Genlian Hu, Qingqing Huang, Congrong Xu, Jiafang Zhang, Fangzhen Wu, Rongbin Song, Hongshan Chen, Feng Zheng

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year
2026

Citation

Zhang, Z., Lin, Z., Hu, G., et al. (2026). JAK Inhibitor Tofacitinib Ameliorates Inflammation Response and Osteogenic Differentiation in Immune‐Mediated Inflammatory Arthritis in Rats. International Journal of Rheumatic Diseases. https://doi.org/10.1111/1756-185x.70773

Related articles